News

During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...

This is the 15th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. You can read the first part here. The series...

Justin Schleede reaches onto a black lab bench to pick up a tray of small plastic tubes.

"These are saliva...

"If proven to be safe, we believe preventive gene editing could be one of the most important health technologies of...

By Brisbane Times, Brisbane Times | 06.19.2008

New Zealand parents involved in IVF programs could soon be allowed to choose the sex of their child if the...

By Bernadette Tansey, San Francisco Chronicle | 06.17.2008
The veteran Silicon Valley venture capital firm that helped found the biotechnology industry, Kleiner Perkins Caufield & Byers, is now...
Press Statement

Hearing on "Genetics and other Human Modification Technologies" will be webcast

Richard Hayes, the executive director of the Center for Genetics and Society, will testify before the US House Foreign Affairs Committee Subcommittee on Terrorism, Nonproliferation and Trade on Thursday June 19. The subcommittee, chaired by Rep. Brad Sherman (D-Los Angeles), will hold a hearing on "Genetics and other Human Modification Technologies: Sensible International Regulation or a New Kind of Arms Race."

"Genetics and other Human Modification Technologies: Sensible International Regulation or a New Kind of Arms Race"
Hearing of House Subcommittee on Terrorism, Nonproliferation and Trade
Thursday June 19 at 10 AM
2200 Rayburn House Office Building
webcast at the subcommittee's website

Speakers will include:

  • Richard Hayes, Ph.D., Executive Director, Center for Genetics and Society
  • Jamie F. Metzl, Ph.D, Executive Vice President, Asia Society
  • Paul R. Billings M.D., Ph.D., President and Chief Executive Officer, Cellpoint Diagnostics, Inc.
  • Nigel M. de S. Cameron, Ph.D., President and Co-founder, Institute on Biotechnology and the Human Future

Topics will include:

  • the social challenges posed by human biotechnologies
  • the threat of genetically modified bioweapons
  • the state of international policy regulating these technologies
  • the shape of possible global regulatory agreements.

Dr. Hayes will address the question, "Is There an Emerging International Consensus on the Proper Uses of the New Human Genetic Technologies?" His prepared testimony is available [PDF] at the Center's website.

The hearing is scheduled for 10:00 a.m. in 2200 Rayburn House Office Building, and will be webcast. For more information, see the subcommittee's website.

The Center for Genetics and Society is a public affairs and policy advocacy organization working to encourage responsible uses and effective societal governance of human biotechnologies.


Contact:
Jesse Reynolds
jreynolds[AT]geneticsandsociety[DOT]org
1-510-625-0819 x308

Richard Hayes
rhayes[AT]geneticsandsociety[DOT]org
1-510-332-1769


 

By Marcus Wohlsen, San Francisco Chronicle | 06.16.2008
California health regulators have demanded that 13 direct-to-consumer genetic testing startups halt sales in the state until they prove they...
By Olga Craig, Telegraph [UK] | 06.16.2008

When the first test-tube baby was born, it wasn't just the beginning of a new life but of a whole...

By Osagie K. Obasogie, Alternet | 06.16.2008

Good Morning America recently televised a world exclusive that caught many pet owners' attention: Dog cloning is now commercially available...

By Mark Henderson, The Times | 06.14.2008
A loophole in the Human Fertilisation and Embryology Bill could permit some reproductive cloning without the need for fresh primary...
By Edinburgh Evening News, Edinburgh Evening News | 06.12.2008

THE World Anti-Doping Agency has called for increased awareness of the dangers of gene doping.
Defined by WADA as "the...